Gene · 8322
Papers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,273
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem. | Cancers (Basel) | 2022 | 36497343 | PubTator, text mining | PubMed |
| Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. | Cancers (Basel) | 2022 | 36497264 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling. | Cells | 2022 | 36497082 | PubTator, text mining | PubMed |
| Expression of hub genes of endothelial cells in glioblastoma-A prognostic model for GBM patients integrating single-cell RNA sequencing and bulk RNA sequencing. | BMC Cancer | 2022 | 36474171 | PubTator, text mining | PubMed |
| Comprehensive Genomic Analysis for Identifying FZD6 as a Novel Diagnostic Biomarker for Acute Myeloid Leukemia. | Comput Math Methods Med | 2022 | 36452482 | PubTator, text mining | PubMed |
| NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo. | BMC Urol | 2022 | 36434587 | PubTator, text mining | PubMed |
| CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis. | BMC Pulm Med | 2022 | 36434577 | PubTator, text mining | PubMed |
| Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases. | Pharmaceutics | 2022 | 36432666 | PubTator, text mining | PubMed |
| Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling? | Biomed Pharmacother | 2022 | 36411643 | PubTator, text mining | PubMed |
| Clinical characteristics and mutation spectrum in 33 Chinese families with familial exudative vitreoretinopathy. | Ann Med | 2022 | 36411543 | PubTator, text mining | PubMed |
| Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease. | Can J Gastroenterol Hepatol | 2022 | 36397950 | PubTator, text mining | PubMed |
| Circular RNAs in diabetes and its complications: Current knowledge and future prospects. | Front Genet | 2022 | 36386812 | PubTator, text mining | PubMed |
| Transcriptomic profiling of Indian breast cancer patients revealed subtype-specific mRNA and lncRNA signatures. | Front Genet | 2022 | 36386805 | PubTator, text mining | PubMed |
| Noncoding RNAs as a novel approach to target retinopathy of prematurity. | Front Pharmacol | 2022 | 36386230 | PubTator, text mining | PubMed |
| Structure of the GOLD-domain seven-transmembrane helix protein family member TMEM87A. | Elife | 2022 | 36373655 | PubTator, text mining | PubMed |
| Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs. | Int J Mol Sci | 2022 | 36362406 | PubTator, text mining | PubMed |
| Signal Peptide Variants in Inherited Retinal Diseases: A Multi-Institutional Case Series. | Int J Mol Sci | 2022 | 36362148 | PubTator, text mining | PubMed |
| Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence. | Pharmaceuticals (Basel) | 2022 | 36355476 | PubTator, text mining | PubMed |
| Decrease of FZD4 exon 1 methylation in probands from FZD4-associated FEVR family of phenotypic heterogeneity. | Front Med (Lausanne) | 2022 | 36353221 | PubTator, text mining | PubMed |
| Molecular characterization of early breast cancer onset to understand disease phenotypes in African patients. | Med Oncol | 2022 | 36352274 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8322/papers?page=19